Hypokinesia in Huntington's disease

Movement Disorders

Volumn 11, Issue 4, 1996, Pages 384-388

  Van Vugt, Jeroen P P ^a   Van Hilten, Bob J ^a   Roos, Raymund A C ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Activity monitoring; Huntington's disease; Hypokinesia; Neuroleptics

Indexed keywords

HALOPERIDOL; NEUROLEPTIC AGENT; PIMOZIDE; TIAPRIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DISABILITY; FEMALE; HUMAN; HUNTINGTON CHOREA; HYPOKINESIA; MALE; MOTOR ACTIVITY; PRIORITY JOURNAL;

ADULT; AGED; ANTIPSYCHOTIC AGENTS; CIRCADIAN RHYTHM; DISABILITY EVALUATION; FEMALE; HUMANS; HUNTINGTON DISEASE; HYPOKINESIA; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; MOTOR ACTIVITY; PARKINSON DISEASE; REFERENCE VALUES; RISK FACTORS;

EID: 0030057420     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.870110406     Document Type: Article

References (35)

1. Marsden CD. Slowness of movement in Parkinson's disease. Mov Disord 1989;4(suppl 1):S26-S37.
2. Folstein SE, Jensen B, Leigh RJ, Folstein MF. The measurement of abnormal movement: methods developed for Huntington's disease. Neurobehav Toxicol Teratol 1983;5: 605-609.
3. David AS, Jeste DV, Folstein MF, Folstein SE. Voluntary movement dysfunction in Huntington's disease and tardive dyskinesia. Acta Neurol Scand 1987;75:130-139.
4. Hefter H, Hömberg V, Lange HW, Freund H-J. Impairment of rapid movement in Huntington's disease. Brain 1987;110: 585-612.
5. Girotti F, Marano R, Soliveri P, Geminiani G, Scigliano G. Relationship between motor and cognitive disorders in Huntington's disease. J Neurol 1988;235:454-457.
6. Thompson PD, Berardelli A, Rothwell JC, et al. The coexistence of bradykinesia and chorea in Huntington's disease and its implications for theories of basal ganglia control of movement. Brain 1988;111:223-244.
7. Bradshaw JL, Phillips JG, Dennis C, et al. Initiation and execution of movement sequences in those suffering from and at risk of developing Huntington's disease. J Clin Exp Neuropsychol 1992;14:179-192.
8. Machetanz J, Meyer B-U, Bischoff C, Weindl A, Conrad B. Characteristics of hand movements in Huntington's disease. Mov Disord 1992;7(suppl 1):S527.
9. Sprengelmeyer R, Canavan AGM, Lange HW, Hömberg V. Associative learning in degenerative neostriatal disorders: contrasts in explicit and implicit remembering between Parkinson's and Huntington's diseases. Mov Disord 1995;10: 51-65.
10. Bruyn GW. The Westphal variant and juvenile type of Huntington's chorea. In: Barbeau A, Brunette JR, eds. Progress in neuro-genetics. Amsterdam: Excerpta Medica Foundation, 1969:666-673. (International congress series; no. 175).
11. Bruyn GW. The Westphal variant and juvenile type of Huntington's chorea. In: Barbeau A, Brunette JR, eds. Progress in neuro-genetics. Amsterdam: Excerpta Medica Foundation, 1969:666-673. (International congress series; no. 175).
12. Bittenbender JB, Quadfasel FA. Rigid and akinetic forms of Huntington's chorea. Arch Neurol 1962;7:275-288.
13. Denny-Brown D. Diseases of the basal ganglia: their relation to disorders of movement. Lancet 1960;2:1099-1105, 1155-1162.
14. Van Hilten JJ, Hoogland G, Van der Velde EA, Kerkhof GA, Van Dijk JG, Roos RAC. Quantitative assessment of parkinsonian patients by continuous wrist activity monitoring. Clin Neuropharmacol 1993;16:36-45.
15. Huntington Study Group. Unified Huntington's Disease Rating Scale: reliability and consistency. Mov Disord 1996;11: 136-142.
16. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
17. Van Hilten JJ, Middelkoop HAM, Kuiper SIR, Kramer CGS, Roos RAC. Where to record motor activity: an evaluation of commonly used sites of placement for activity monitors. Electroencephalogr Clin Neurophysiol 1993;89: 359-362.
18. Redmond DP, Hegge FW. Observations on the design and specifications of a wrist-worn human activity monitoring system. Behav Res Methods Instrum Comput 1985;17:659-669.
19. Kramer CGS, Middelkoop HAM, Van Hilten JJ, Kamphuisen HAC. Actplan and actstat: software programs for analyzing motor activity data as obtained with commercial actigraphs. J Ambul Monit 1992;5:331-340.
20. Burns A, Folstein S, Brandt J, Folstein M. Clinical assessment of irritability, aggression, and apathy in Huntington and Alzheimer disease. J Nerv Ment Dis 1990;178:20-26.
21. Penney JB, Young AB. Striatal inhomogeneities and basal ganglia function. Mov Disord 1986;1:3-15.
22. Percheron G, Parent A, Crossman A, et al. Substrat anatomo-physiologique de l'akinésie chez le primate. Rev Neurol (Paris) 1990;146:575-584.
23. Crossman AR, Mitchell IJ, Sambrook MA, Jackson A. Chorea and myoclonus in the monkey induced by gamma-aminobutyric acid antagonism in the lentiform complex. Brain 1988;111:1211-1233.
24. Lee MS, Marsden CD. Movement disorders following lesions of the thalamus or subthalamic region. Mov Disord 1994;9:493-507.
25. Emson PC, Arregui A, Clement-Jones V, Sandberg BEB, Rossor M. Regional distribution of methionine-enkephalin and substance P-like immunoreactivity in normal human brain and in Huntington's disease. Brain Res 1980;199:147-160.
26. Grafe MR, Forno LS, Eng LF. Immunocytochemical studies of substance P and met-enkephalin in the basal ganglia and substantia nigra in Huntington's, Parkinson's and Alzheimer's diseases. J Neuropathol Exp Neurol 1985;44:47-59.
27. Bird ED. Huntington's chorea: etiology and pathogenesis. In: Vinken PJ, Bruyn GW, Klawans HL, eds. Extrapyramidal disorders. Amsterdam: Elsevier, 1986:255-265. (Handbook of clinical neurology; vol 5).
28. Bird ED. Huntington's chorea: etiology and pathogenesis. In: Vinken PJ, Bruyn GW, Klawans HL, eds. Extrapyramidal disorders. Amsterdam: Elsevier, 1986:255-265. (Handbook of clinical neurology; vol 5).
29. Albin RL, Reiner A, Anderson KD, Penney JB, Young AB. Striatal and nigral neuron subpopulations in rigid Huntington's disease: implications for the functional anatomy of chorea and rigidity-akinesia. Ann Neurol 1990;27:357-365.
30. Storey E, Beat MF. Neurochemical substrates of rigidity and chorea in Huntington's disease. Brain 1993;116:1201-1222.
31. Berretta S, Robertson HA, Graybiel AM. Neurochemically specialized projection neurons of the striatum respond differentially to psychomotor stimulants. Prog Brain Res 1993; 99:201-205.
32. Girotti F, Carella F, Scigliano G, et al. Effect of neuroleptic treatment on involuntary movements and motor performances in Huntington's disease. J Neurol Neurosurg Psychiatry 1984;47:848-852.
33. Shoulson I, Huntington's disease: functional capacities in patients treated with neuroleptic and antidepressant drugs. Neurology 1981;31:1333-1335.
34. Quinn N, Marsden CD. A double blind trial of sulpiride in Huntington's disease and tardive dyskinesia. J Neurol Neurosurg Psychiatry 1984;47:844-847.
35. Feigin A, Kieburtz K, Bordwell K, et al. Functional decline in Huntington's disease. Mov Disord 1995;10:211-214.